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Relationship between β-Thalassemia minor and 
Helicobacter pylori infection 
 
 
Abstract 
Background: Until now, no study has been reported investigating the association between 
β-thalassemia minor and Helicobacter pylori (H. pylori) infection. This study was 
designed to compare H. pylori infection rate between β-thalassemia minor patients and 
healthy controls. 
Methods: A number of 100 β-thalassemia minor patients (50 males, 50 females) and 100 
gender-matched healthy controls were prospectively recruited in this study in a period of 3 
months. The study population consisted of the people who referred to a health center in 
Babol, North of Iran, for premarital counseling. H. pylori status was assessed by measuring 
the anti-H. pylori IgG antibodies using enzyme-linked immunosorbent assay. 
Demographic information and informed consent were collected from all participants. 
Results: The overall H. pylori infection rate was 43%. The infection was significantly 
more prevalent in thalassemia patients (53%) than in the controls (33%) in both univariate 
(OR=2.29, 95% CI: 1.3-4.06) and multivariable analyses (OR=2.05, 95% CI: 1.12-3.76). 
Age was the only significant factor which was positively correlated with the infection in β-
thalassemia minor cases (OR=1.11, 95% CI: 1.02-1.2). Gender, blood groups, residency, 
and education level were not related to the infection. 
Conclusions: According to the results, it can be concluded that β-thalassemia minor 
patients are possibly more susceptible to H. pylori infection than healthy people. Further 
studies are needed to discover more about the exact mechanisms of increased susceptibility 
to H. pylori infection in β-thalassemia minor patients. 
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Thalassemia is a common genetic disorder characterized by a point mutation on 
globin gene expression(1). β-thalassemia is the result of impaired production of β-globin 
chains. This hemoglobinopathy has three principal forms, including thalassemia major, 
thalassemia intermedia and thalassemia minor (2). The clinical manifestations, such as 
mild microcytic and hypochromic anemia, are fully related to level of production of β-
globin chain (3). The prevalence of β-thalassemia is seen more frequently in the 
Mediterranean countries, the Middle East and Central Asia (1, 4). Helicobacter pylori (H. 
pylori), a gram-negative bacterium, colonizes the human gastric mucosa. This pathogen is 
the main cause of chronic gastritis, peptic ulcer, gastric cancer and dyspepsia (5, 6). The 
prevalence of H. pylori infection is seen in about half of the worldwide population and it is 
higher in the developing countries than in the developed countries (7, 8). Iran, a country, in 
the Middle East is an endemic region of thalassemia. About 20,000 homozygote β-
thalassemia and 3,750,000 carriers have been identified in this country (9). All couples 
should be checked for β-thalassemia before marriage in Iran and those who are both 
carriers receive premarital counselling (10, 11).    
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In North of Iran, β-thalassemia minor is the most 
frequent state of β-thalassemia and is estimated about 10% 
of the population(12). Taking into account the remarkable 
concurrent prevalence of β-thalassemia minor and H. pylori 
infection in northern Iran(10, 12, 13), and considering the 
high rate of gastric diseases among these thalassemia 
patients in this area, it appears that there may be an 
association between H. pylori and β-thalassemia minor. 
There have been some articles showing a probable 
relationship between H. pylori and recurrent abdominal pain 
(RAP) in people with hemoglobinopathies, such as sickle 
cell anemia and β-thalassemia (14, 15).  
In a survey by Karimi et al.(16), H. pylori infection in the 
β-thalassemia major patients with RAP was more common 
than in non-thalassemic controls with RAP. Although the 
difference was not significant, the authors suggested that H. 
pylori can possibly increase the risk of RAP in thalassemia 
patients (16).  
In the present study, we aimed to compare the prevalence 
of H. pylori infection between β-thalassemia minor patients 
and normal controls in Babol, north of Iran. 
 
 
Methods 
Study population and data collection: This prospective 
study was performed on the people who refered to one of the 
health centers in Amirkola, Babol. This place is the major 
referral center for premarital thalassemia sreening in Babol. 
A series of 100 persons who were confirmed diagnosis of 
β-thalassemia minor were consecutively included in the 
study (50 males, 50 females) during December 2015-
February 2016. To confirm β-thalassemia minor, all 
participants' blood samples were checked initially for 
complete blood count (mean corpuscular volume<80 and 
mean corpuscular hemoglobin<27) and then for hemoglobin 
A2 using high-performance liquid chromatography 
(hemoglobin A2>3.5).  
An equal number of controls, whose genders were 
compatible, were enrolled in this survey. The recruited 
controls were those who referred to the same health center. 
Demographic information (age, gender, blood group, 
residency, and education level) was obtained from all 
individuals.  
Serum samples of the groups were collected and 
transmited to the immunology laboratory of Babol 
University of Medical Sciences and stored frozen at -20°C. 
To determine the infection, anti-H. pylori IgG antibodies 
were measured using enzyme-linked immunosorbent assay 
(ELISA) kits (IBL, Hamburg, Germany). Samples were 
considered positive for H. pylori when the antibody levels 
were more than 12 U/ml. 
The study was approved by the Ethics Committee of 
Babol University of Medical Sciences and Health Services, 
the reference number is MUBABOL.REC.1395.71. Written 
informed consent was taken from all participants. 
Chi-square and student's t-test were used to compare the 
demographic factors between case and control groups. To 
evaluate the association between H. pylori infection and β-
thalassemia minor, we used the multivariable logistic 
regression analysis adjusted for residency and education by 
calculating odds ratio (OR) and 95% confidence interval 
(CI). The univariate analysis was performed to determine the 
relationship between the demographic variables and H. 
pylori infection in the β-thalassemia minor patients. A 
p<0.05 was considered statistically significant. 
 
 
Results 
The mean age of β-thalassemia minor and control 
subjects was 25.21±5.92 (range, 14-46) and 26.12±7.13 
(range, 14-68) years, respectively. Fifty-one percent of the 
individuals had blood type O, and majority of them (97%) 
were RH positive. Forty- eight percent of β-thalassemia 
minor patients and 65% of controls were urban inhabitants, 
and the difference was significant (P=0.015). There were 
significant differences between the two groups in the 
educational status and thalassemia subjects have lower level 
of education than controls (p<0.001) (table 1). 
Overall, the prevalence of H. pylori was 43% in the study 
population. This rate was higher in β-thalassemia minor 
group (53%) compared with controls (33%), and the 
difference was significant (odds ratio [OR]=2.29, 95% CI: 
1.3-4.06, P=0.005). This significant difference was observed 
between the groups even after adjustment for residency and 
education (OR=2.05, 95% CI: 1.12-3.76, P=0.02) (table 2). 
Table 3 shows the association between H. pylori 
infection and risk factors in the β-thalassemia minor cases. 
Age was the only factor significantly positively associated 
with the infection (OR=1.11, 95% CI: 1.02-1.2). No 
significant correlation was found between H. pylori infection 
and other variables, including gender, ABO and Rh blood 
groups, residency, and education. 
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Table 1. Demographic characteristics of the participants 
 Thalassemia 
n(%) 
Control 
n(%) 
P-value 
Gender    
1 Male 50 (50) 50 (50) 
Female 50 (50) 50 (50) 
Age (year) 25.21±5.92 26.12±7.13 0.327 
ABO Blood group    
0.972 A 15 (15) 17 (17) 
B 28 (28) 27 (27) 
AB 6 (6) 5 (5) 
O 51 (51) 51 (51) 
Rhesus (Rh) blood groups    
1 Rh Positive 97 (97) 97 (97) 
Rh Negative 3 (3) 3 (3) 
Residency    
0.015 Urban 48 (48) 65 (65) 
Rural 52 (52) 35 (35) 
Education level    
0.0001 Below diploma 36 (36) 12 (12) 
Diploma 20 (20) 28 (28) 
Bachelor’s degree 44 (44) 60 (60) 
 100 subject in each group 
 
Table 2. Comparison of H. pylori infction between β-thalassemia minor and normal subjects 
 
 H. pylori positive 
N (%) 
Univariate 
OR (95% CI) 
P-value Adjusted
a
  
OR (95% CI) 
P-value 
Normal 33 (33) 1  1  
β-thalassemia minor 53 (53) 2.29 (1.3-4.06) 0.005 2.05 (1.12-3.76) 0.02 
aAdjusted for residency and education. CI: confidence interval; OR: odds ratio 
 
Table 3. Relationship between H. pylori infection and sociodemographic factors of β-thalassemia minor patients 
 H. pylori positive 
n(%) 
H. pylori negative 
n(%) 
OR (95% CI) P-value 
Gender      
Male 30 (60) 20 (40) 1  
Female 23 (46) 27 (54) 0.57 (0.25-1.25) 0.16 
Age - - 1.11 (1.02-1.2) 0.009 
ABO Blood group     
A 9 (60) 6 (40) 1  
B 14 (50) 14 (50) 0.66 (0.18-2.37) 0.532 
AB 4 (66.7) 2 (33.3) 1.33 (0.18-9.72) 0.777 
O 26 (51) 25 (49) 0.7 (0.21-2.23) 0.539 
Residency      
Urban 23 (48) 25 (52) 1  
Rural 30 (57.7) 22 (42.3) 1.49 (0.67-3.26) 0.329 
Education level     
Below diploma 23 (64) 13 (36) 1  
Diploma  11 (55) 9 (45) 0.7 (0.22-2.1) 0.515 
Bachclors degree 19 (43) 25 (57) 0.43 (0.17-1.06) 0.067 
CI: Confidence Interval; OR: Odds Ratio 
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Discussion 
According to the results of this study, the prevalence of 
H. pylori infection was significantly higher in β-thalassemia 
minor patients than in the normal subjects. This is the first 
study reporting a significant association between β-
thalassemia minor and H. pylori infection. In the past, few 
studies were performed to investigate the relationship 
between H. pylori infection and hemoglobinopathies, such as 
sickle cell anemia and β-thalassemia major, mostly based on 
determining the role of this pathogen in the occurrence of 
RAP in the patients with such diseases. Regarding sickle cell 
anemia, studies demonstrated controversial results about the 
relationship between H. pylori infection and this anemia (15, 
17, 18). On the other hand, in relation to β-thalassemia 
major, surveys revealed no significant association between 
the infection and thalassemia. In their study, Karimi et 
al.(16) reported that the rate of H. pylori positivity in the β-
thalassemia major patients with RAP was a little higher than 
in the healthy controls with the same symptoms (68% 
compared with 60%, p>0.05). Although the difference was 
not statistically significant, the authors proposed this 
pathogen as a potential cause of the RAP in the thalassemia 
patients(16). Also, the study by Balci et al.(14) indicated no 
significant differences between β-thalassemia major patients 
and non-thalassemic controls, both presenting with RAP, 
neither in serum anti-H. pylori IgG ELISA test (58.1% in 
comparison with 48.8%) nor in urea-breath test (48.4% 
compared with 39%). Nevertheless, there was not any report 
about the association of β-thalassemia minor with H. pylori 
infection and additional investigations are needed. 
We believe that higher H. pylori infection rate in the β-
thalassemia minor patients compared with controls in our 
study, may be related to the overload of iron. It is well-
documented that iron is one of the essential factors for the 
pathogens to thrive in the host environment (19, 20), and H. 
pylori is no exception. Some published data proposed that H. 
pylori infection may cause iron-related diseases, such as 
anemia, iron deficiency, and iron deficiency anemia, in both 
children and adults (21-23), although other reports were not 
in accordance with these findings (24, 25). Considering that 
previous studies suggested a correlation between iron 
overload and increased risk of infections in the β-thalassemia 
patients (4, 26, 27), and also given that the iron excess can 
be seen mildly in the β-thalassemia minor patients(28, 29), it 
can be concluded that the overload of iron may lead to 
increase susceptibility to H. pylori infection. However, there 
is still no evidence supporting the hypothesis that iron 
overload is responsible for H. pylori infection in the β-
thalassemia minor patients. So, more surveys should be done 
to uncover this dilemma. 
In our study, it was observed that the seroprevalence of 
H. pylori had a positive correlation with age. This finding is 
in agreement with the previous literature showing the effect 
of birth cohort on H. pylori infection (30-32). By contrast, 
the prevalence of H. pylori was not different between two 
genders. There are no compatible findings on this topic. 
Moreover, the question of who is more susceptible to 
infection has remained open, that is, it is not clear if the 
infection occurred more frequently in males or in females 
(33-36). Regarding blood groups, no significant relationships 
were found between H. pylori positivity and blood groups 
ABO and Rh in the present study. While some previous 
reports alluded to these correlations (37, 38), others refuted 
them (39, 40).  
Besides, there were no associations found between H. 
pylori infection and residency and education. With regard to 
this subject, previous surveys indicated that low 
socioeconomic status can increase the risk of infection. Yet, 
there were inconsistent results whether the infection rate is 
higher in inhabitants of rural areas or in people living in the 
cities (41, 42). Furthermore, H. pylori infection has been 
identified less frequently in people with higher levels of 
education than persons with lower education in most of the 
studies (43-45). These different findings show that high 
literacy of the individuals can cause them to pay more 
attention to health and hygiene issues.  
A limitation of our survey was that the sample size was 
relatively small for assessing the relation between infection 
and variables in the thalassemia group. Definitely, the 
number of sample size was enough for evaluating the main 
purpose of the study, given that a significant correlation was 
found between beta-thalassemia minor and H. pylori 
infection. 
In conclusion the results indicated that β-thalassemia 
minor patients are about two times more at risk of H. pylori 
infection in comparison with controls. The infection was 
significantly associated with age and not with type of blood, 
residency and education among the thalassemia patients. 
Further studies are needed to be designed for a more precise 
investigation of the mechanisms leading to increased 
susceptibility to H. pylori infection in β-thalassemia minor 
patients. 
 Caspian J Intern Med 2018; 9(1):54-59  
58                                        Zamani M, et al. 
Acknowledgments 
The authors would like to thank the staff of the Health 
Center of Amirkola, Babol, for their kind efforts. 
 
Funding: This study was financially supported by the Vice-
Chancellery for Research and Technology of Babol 
University of Medical Sciences. 
Competing Interests: The authors declare no conflict of 
interest. 
 
 
References 
1. Cao A, Galanello R. Beta-thalassemia. Genet Med 2010; 
12: 61-76. 
2. Thein SL. The molecular basis of β-thalassemia. Cold 
Spring Harb Perspect Med 2013; 3: a011700. 
3. Nienhuis AW, Nathan DG. Pathophysiology and clinical 
manifestations of the β-thalassemias. Cold Spring Harb 
Perspect Med 2012; 2: a011726. 
4. Vento S, Cainelli F, Cesario F. Infections and 
thalassaemia. Lancet Infect Dis 2006; 6: 226-33. 
5. McColl KE. Clininal practice. Helicobacter pylori 
infection. N Engl J Med 2010; 362: 1597-604. 
6. Mentis A, Lehours P, Mégraud F. Epidemiology and 
diagnosis of Helicobacter pylori infection. Helicobacter 
2015; 20: 1-7. 
7. Eusebi LH, Zagari RM, Bazzoli F. Epidemiology of 
helicobacter pylori infection. Helicobacter 2014; 19: 1-5. 
8. Malfertheiner P, Megraud F, O'morain C, et al. 
Management of Helicobacter pylori infection-the 
Maastricht V/Florence consensus report. Gut 2016; 66: 6-
30. 
9. Hashemizadeh H, Noori R. Premarital Screening of Beta 
Thalassemia Minor in north-east of Iran. Iran J Ped 
Hematol Oncol 2013; 3: 210-5. 
10. Zeinalian M, Nobari RF, Moafi A, Salehi M, 
Hashemzadeh-Chaleshtori M. Two decades of pre-
marital screening for beta-thalassemia in central Iran. J 
Community Genet 2013; 4: 517-22. 
11. Abolghasemi H, Amid A, Zeinali S, et al. Thalassemia in 
Iran: epidemiology, prevention, and management. J 
Pediatr Hematol Oncol 2007; 29: 233-8. 
12. Miri M, Tabrizi Namini M, et al. Thalassemia in Iran in 
Last Twenty Years: the Carrier Rates and the Births 
Trend. Iran J Blood Cancer 2013; 6: 11-7. 
13. Khedmat H, Karbasi-Afshar R, Agah S, Taheri S. 
Helicobacter pylori Infection in the general population: A 
Middle Eastern perspective. Caspian J Intern Med 2013; 
4: 745-53. 
14. Balci YI, Aral YZ, Covut IE, Polat Y, Turk M, Acimis N. 
The frequency of Helicobacter Pylori infection in Beta 
Thalassemia major Patients with recurrent abdominal 
pain. Pak J Med Sci 2011; 27: 316-9. 
15. Woods KF, Onuoha A, Schade RR, Kutlar A. 
Helicobacter pylori infection in sickle cell disease. J Natl 
Med Assoc 2000; 92: 361-5. 
16. Karimi M, Imanieh MH, Ghiam AF, Hashemi Z. 
Investigation of Helicobacter pylori infection in β-
thalassaemia major patients with recurrent abdominal 
pain. Eur J Gastroenterol Hepatol 2005; 17: 1363-7. 
17. Kennedy L, Mahoney DH, Redel CA. Helicobacter 
pylori gastritis in a child with sickle cell anemia and 
recurrent abdominal pain. J Pediatr Hematol Oncol 1997; 
19: 163-4. 
18. Senbanjo I, Akinbamig A, Diaku-Akinwumi I, et al. 
Helicobacter pylori infection among a pediatric 
population with sickle cell disease. J Natl Med Assoc 
2010; 102: 1095-9. 
19. Ganz T, Nemeth E. Iron homeostasis in host defence and 
inflammation. Nat Rev Immunol 2015; 15: 500-10. 
20. Skaar EP. The battle for iron between bacterial pathogens 
and their vertebrate hosts. PLoS Pathog 2010; 6: 
e1000949. 
21. Queiroz DM, Harris PR, Sanderson IR, et al. Iron status 
and Helicobacter pylori infection in symptomatic 
children: an international multi-centered study. PLoS 
One 2013; 8: e68833. 
22. Zamani M, Masrour-Roudsari J, Zamani V. Hematologic 
disorder: A manifestation of helicobacter pylori infection. 
Caspian J Intern Med 2017; 8: 133-4. 
23. Soundaravally R, Pukazhvandthen P, Zachariah B, 
Hamide A. Plasma ferritin and indices of oxidative stress 
in Helicobacter pylori infection among schoolchildren. J 
Pediatr Gastroenterol Nutr 2013; 56: 519-22. 
24. Xie C, Xu LY, Li W, et al. Helicobacter pylori infection 
in Mongolian gerbils does not initiate hematological 
diseases. World J Gastroenterol 2014; 20: 12308-12. 
25. Noto JM, Gaddy JA, Lee JY, et al. Iron deficiency 
accelerates Helicobacter pylori-induced carcinogenesis in 
rodents and humans. J Clin Invest 2013; 123: 479-92. 
 Caspian J Intern Med 2018; 9(1):54-59  
Helicobacter pylori and β-Thalassemia Minor                              59 
26. Rahav G, Volach V, Shapiro M, et al. Severe infections 
in thalassaemic patients: prevalence and predisposing 
factors. Br J Haematol 2006; 133: 667-74. 
27. Galanello R, Origa R. Beta-thalassemia. Orphanet J Rare 
Dis 2010; 5: 11. 
28. Mosca A, Paleari R, Ivaldi G, Galanello R, Giordano PC. 
The role of haemoglobin A2 testing in the diagnosis of 
thalassaemias and related haemoglobinopathies. J Clin 
Pathol 2009; 62: 13-7. 
29. Piperno A, Mariani R, Arosio C, Vergani A, et al. 
Haemochromatosis in patients with β‐thalassaemia trait. 
Br J Haematol 2000; 111: 908-14. 
30. Okuda M, Osaki T, Lin Y, et al. Low prevalence and 
incidence of helicobacter pylori infection in children: a 
population‐based study in Japan. Helicobacter 2015; 20: 
133-8. 
31. Yucel O. Prevention of Helicobacter pylori infection in 
childhood. World J Gastroenterol 2014; 20: 10348-54. 
32. Ozbey G, Dogan Y, Demiroren K. Prevalence of 
Helicobacter pylori virulence genotypes among children 
in Eastern Turkey. World J Gastroenterol 2013; 19: 
6585-9. 
33. Singh V, Trikha B, Nain CK, Singh K, Vaiphei K. 
Epidemiology of Helicobacter pylori and peptic ulcer in 
India. J Gastroenterol Hepatol 2002; 17: 659-65. 
34. Shi R, Xu S, Zhang H, et al. Prevalence and risk factors 
for Helicobacter pylori infection in Chinese populations. 
Helicobacter 2008; 13: 157-65. 
35. Moayyedi P, Axon AT, Feltbower R, et al. Relation of 
adult lifestyle and socioeconomic factors to the 
prevalence of Helicobacter pylori infection. Int J 
Epidemiol 2002; 31: 624-31. 
36. Agah S, Khedmat H, Ghamar-Chehred ME, Hadi R, 
Aghaei A. Female gender and Helicobacter pylori 
infection, the most important predisposition factors in a 
cohort of gastric cancer: A longitudinal study. Caspian J 
Intern Med 2016; 7: 136-41. 
37. Ansari SA, Khan A, Khan TA, et al. Correlation of ABH 
blood group antigens secretion with Helicobacter pylori 
infection in Pakistani patients. Trop Med Int Health 
2015; 20: 115-9. 
38. Rasmi Y, Makhdoomi K, Farshid S, Kheradmand F. 
Seroprevalence of anti-helicobacter pylori and 
anticytotoxin-associated gene a antigen antibodies 
according to abo blood groups and rhesus status among 
hemodialysis patients. Iran J Kidney Dis 2011; 5: 110-3. 
39. Aryana K, Keramati MR, Zakavi SR, Sadeghian MH, 
Akbari H. Association of Helicobacter pylori infection 
with the Lewis and ABO blood groups in dyspeptic 
patients. Niger Med J 2013; 54: 196-9. 
40. Petrović M, Artiko V, Novosel S, et al. Relationship 
between Helicobacter pylori infection estimated by 14C-
urea breath test and gender, blood groups and Rhesus 
factor. Hell J Nucl Med 2010; 14: 21-4. 
41. Ozaydin N, Turkyilmaz SA, Cali S. Prevalence and risk 
factors of helicobacter pylori in Turkey: a nationally-
representative, cross-sectional, screening with the 13 C-
Urea breath test. BMC Public Health 2013; 13: 1215. 
42. Baingana RK, Enyaru JK, Davidsson L. Helicobacter 
pylori infection in pregnant women in four districts of 
Uganda: role of geographic location, education and water 
sources. BMC Public Health 2014; 14: 915. 
43. Cheng H, Hu F, Zhang L, et al. Prevalence of 
Helicobacter pylori infection and identification of risk 
factors in rural and urban Beijing, China. Helicobacter 
2009; 14: 128-33. 
44. Nouraie M, Latifi‐Navid S, Rezvan H, et al. Childhood 
hygienic practice and family education status determine 
the prevalence of Helicobacter pylori infection in Iran. 
Helicobacter 2009; 14: 40-6. 
45. Tonkic A, Tonkic M, Lehours P, Mégraud F. 
Epidemiology and diagnosis of Helicobacter pylori 
infection. Helicobacter 2012; 17: 1-8. 
 
 
